3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
8
cyclopia sequence
6
Prostatic Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Hematologic Diseases
2
Head and Neck Neoplasms
2
Fatigue
2
Warts
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Intraepithelial Neoplasia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Papilloma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuromyelitis Optica
1
Myelitis, Transverse
1
Myelitis
1
Melanoma
1
Interventions
Sirolimus
4
nintedanib
1
Sugars
1
Resveratrol
1
Octreotide
1
Loratadine
1
Letrozole
1
Everolimus
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphangioleiomyomatosis
×
Sugars
×
Clear all
NCT01353209
2024-04-17
TRAIL
University of Cincinnati
Phase 2
Completed
17 enrolled
13 charts